A detailed history of Fiducient Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Fiducient Advisors LLC holds 4,810 shares of AMGN stock, worth $1.35 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
4,810
Previous 5,023 4.24%
Holding current value
$1.35 Million
Previous $1.57 Million 1.27%
% of portfolio
0.18%
Previous 0.22%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$309.38 - $337.38 $65,897 - $71,861
-213 Reduced 4.24%
4,810 $1.55 Million
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $71,993 - $87,490
274 Added 5.77%
5,023 $1.57 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $121,529 - $146,701
452 Added 10.52%
4,749 $1.35 Million
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $163,648 - $184,614
640 Added 17.5%
4,297 $1.24 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $799,603 - $992,729
3,657 New
3,657 $982,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Fiducient Advisors LLC Portfolio

Follow Fiducient Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiducient Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fiducient Advisors LLC with notifications on news.